(BLTE) Belite Bio - Performance 59.6% in 12m
Compare BLTE with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
69.36%
#5 in Group
Rel. Strength
92.52%
#599 in Universe
Total Return 12m
59.64%
#18 in Group
Total Return 5y
440.89%
#5 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -1.74%
(?) Percentile in Group
12m Total Return: BLTE (59.6%) vs XBI (-12.1%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: BLTE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BLTE
Total Return (including Dividends) | BLTE | XBI | S&P 500 |
---|---|---|---|
1 Month | -15.53% | -14.90% | -7.04% |
3 Months | 7.99% | -14.51% | -10.88% |
12 Months | 59.64% | -12.11% | 5.72% |
5 Years | 440.89% | -20.56% | 100.77% |
Trend Score (consistency of price movement) | BLTE | XBI | S&P 500 |
1 Month | -82.9% | -85.2% | -76.1% |
3 Months | 30.2% | -87.6% | -86.4% |
12 Months | 78.1% | -24% | 67.8% |
5 Years | 83.8% | -52.8% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #89 | -0.74% | -9.13% |
3 Month | #17 | 26.3% | 21.2% |
12 Month | #18 | 81.6% | 51.0% |
5 Years | #6 | 431% | 306% |
FAQs
Does BLTE Belite Bio outperforms the market?
Yes,
over the last 12 months BLTE made 59.64%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months BLTE made 7.99%, while XBI made -14.51%.
Over the last 3 months BLTE made 7.99%, while XBI made -14.51%.
Performance Comparison BLTE vs Indeces and Sectors
BLTE vs. Indices BLTE is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 8.15% | -8.49% | 11.5% | 53.9% |
US NASDAQ 100 | QQQ | 8.64% | -7.67% | 11.6% | 56.0% |
US Dow Jones Industrial 30 | DIA | 6.25% | -10.4% | 9.50% | 53.0% |
German DAX 40 | DAX | -4.35% | -7.48% | -7.11% | 40.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.15% | -7.78% | 6.62% | 51.7% |
Hongkong Hang Seng | HSI | 0.48% | -4.38% | 10.1% | 43.5% |
India NIFTY 50 | INDA | 4.14% | -19.0% | 12.1% | 59.0% |
Brasil Bovespa | EWZ | 3.64% | -9.25% | 11.2% | 70.6% |
BLTE vs. Sectors BLTE is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 8.34% | -7.95% | 3.27% | 46.4% |
Consumer Discretionary | XLY | 9.74% | -9.31% | 9.26% | 52.3% |
Consumer Staples | XLP | 2.89% | -15.4% | 3.82% | 47.2% |
Energy | XLE | 7.19% | -3.61% | 12.5% | 72.4% |
Financial | XLF | 5.44% | -10.7% | 3.55% | 40.3% |
Health Care | XLV | 5.74% | -8.75% | 12.7% | 59.8% |
Industrial | XLI | 5.65% | -9.56% | 12.1% | 55.8% |
Materials | XLB | 4.65% | -8.09% | 18.9% | 67.6% |
Real Estate | XLRE | 2.40% | -10.5% | 11.8% | 45.3% |
Technology | XLK | 8.84% | -5.70% | 17.5% | 62.9% |
Utilities | XLU | 2.63% | -13.4% | 7.24% | 33.3% |
Aerospace & Defense | XAR | 3.49% | -14.9% | 2.06% | 36.5% |
Biotech | XBI | 3.63% | -0.63% | 27.4% | 71.8% |
Homebuilder | XHB | 8.76% | -6.32% | 30.9% | 71.3% |
Retail | XRT | 8.39% | -9.78% | 18.8% | 66.7% |